Computational Reprogramming of T Cell Antigen Receptor Binding Properties.

T-cell receptor (TCR) binding to peptide/MHC is key to antigen-specific cellular immunity, and there has been considerable interest in modulating TCR affinity and specificity for the development of therapeutics and imaging reagents. While in vitro engineering efforts using molecular evolution have yielded remarkable improvements in TCR affinity, such approaches do not offer structural control and can adversely affect receptor specificity, particularly if the attraction towards the MHC is enhanced independently of the peptide. Here we describe an approach to computational design that begins with structural information and offers the potential for more controlled manipulation of binding properties. Our design process models point mutations in selected regions of the TCR and ranks the resulting change in binding energy. Consideration is given to designing optimized scoring functions tuned to particular TCR-peptide/MHC interfaces. Validation of highly ranked predictions can be used to refine the modeling methodology and scoring functions, improving the design process. Our approach results in a strong correlation between predicted and measured changes in binding energy, as well as good agreement between modeled and experimental structures.

[1]  K D Wittrup,et al.  In vitro evolution of a T cell receptor with high affinity for peptide/MHC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Matthew R. Clutter,et al.  High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. , 2005, Journal of molecular biology.

[3]  Yi Li,et al.  Directed evolution of human T-cell receptors with picomolar affinities by phage display , 2005, Nature Biotechnology.

[4]  S. Rosenberg,et al.  Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.

[5]  Patrice Duroux,et al.  IMGT/LIGM-DB, the IMGT® comprehensive database of immunoglobulin and T cell receptor nucleotide sequences , 2005, Nucleic Acids Res..

[6]  Olivier Michielin Application de la modélisation moléculaire à de nouvelles approches thérapeutiques du cancer , 2007 .

[7]  O. Michielin [Application of molecular modeling to new therapeutic cancer approaches]. , 2007, Bulletin du cancer.

[8]  B. Kuhlman,et al.  Structure-based protocol for identifying mutations that enhance protein-protein binding affinities. , 2007, Journal of molecular biology.

[9]  Yi Li,et al.  High-Affinity TCRs Generated by Phage Display Provide CD4+ T Cells with the Ability to Recognize and Kill Tumor Cell Lines1 , 2007, The Journal of Immunology.

[10]  R. Phillips,et al.  Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor , 2008, Nature Medicine.

[11]  Zhiping Weng,et al.  Structure‐based design of a T‐cell receptor leads to nearly 100‐fold improvement in binding affinity for pepMHC , 2009, Proteins.

[12]  Kurt H Piepenbrink,et al.  T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. , 2009, Immunity.

[13]  James McCluskey,et al.  Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability , 2010, Proceedings of the National Academy of Sciences.

[14]  Daniel Coombs,et al.  Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time , 2010, Immunity.

[15]  Sergey Lyskov,et al.  PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta , 2010, Bioinform..

[16]  Samuel L. DeLuca,et al.  Practically Useful: What the Rosetta Protein Modeling Suite Can Do for You , 2010, Biochemistry.

[17]  D. Baker,et al.  Role of conformational sampling in computing mutation‐induced changes in protein structure and stability , 2011, Proteins.

[18]  B. Baker,et al.  Disparate degrees of hypervariable loop flexibility control T-cell receptor cross-reactivity, specificity, and binding mechanism. , 2011, Journal of molecular biology.

[19]  K. Garcia,et al.  T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. , 2011, Immunity.

[20]  B. Baker,et al.  TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms , 2011, The Journal of Immunology.

[21]  Yvonne McGrath,et al.  Monoclonal TCR-redirected tumor cell killing , 2012, Nature Medicine.

[22]  Brian M. Baker,et al.  The basis for limited specificity and MHC restriction in a T cell receptor interface , 2013, Nature Communications.

[23]  Jack Snoeyink,et al.  Scientific benchmarks for guiding macromolecular energy function improvement. , 2013, Methods in enzymology.

[24]  David M. Kranz,et al.  Role of T Cell Receptor Affinity in the Efficacy and Specificity of Adoptive T Cell Therapies , 2013, Front. Immunol..

[25]  Timothy Cardozo,et al.  Specific Increase in Potency via Structure-Based Design of a TCR , 2014, The Journal of Immunology.

[26]  Zhiping Weng,et al.  Computational Design of the Affinity and Specificity of a Therapeutic T Cell Receptor , 2014, PLoS Comput. Biol..